Totally. With the upcoming launch of Braun's new Glucose device with LifeSpot on the backend in Feb and news from the US wrt Insulin Pen maker and other things, high chances of a multi bag. If we get the Insulin Pen deal might be do a MVP. We also have a large investor on board with links to Diabetes Australia. Work will commence of 5-6 other Braun products integration with Bodytel. Also, have TK Pharma and Anycare in train.
With respect to the SEC - US deregisteration etc questions that one of the posters raised, I have been able to get in touch with the management for further clarification. Will report back when I hear from them.
